To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Behind the scenes of Southern ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Biotech Labz Supply has announced an exciting expansion of its product line, focusing on research peptides that are gaining attention in the scientific community. As a leading supplier of high-quality ...

Get the latest federal technology news delivered to your inbox. The congressional working group on the national security ramifications of biotechnology is angling to publish and deliver new policy ...

Moderna's early hantavirus vaccine research has boosted stock price, reflecting market interest. The vaccine is in initial ...

When Tiba Biotech was included in the cancellation of $500 million worth of grants funding mRNA vaccine development, the company was shocked. That’s because Tiba’s project doesn’t use mRNA and is not ...

In a quiet business park far from Seattle's booming South Lake Union, players in the Northwest's "other" tech sector are coping with growing pains of their own. (Phys.org) —A team of researchers ...

A group of biotechnology research companies based in Birmingham will receive $44 million in federal funding to research AI technology, federal officials announced this morning. The Birmingham ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 by 9 percentage ...

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...